Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FOXP1 is a regulator of quiescence in healthy human CD4+ T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders.
Garaud S, Roufosse F, De Silva P, Gu-Trantien C, Lodewyckx JN, Duvillier H, Dedeurwaerder S, Bizet M, Defrance M, Fuks F, Bex F, Willard-Gallo K. Garaud S, et al. Among authors: de silva p. Eur J Immunol. 2017 Jan;47(1):168-179. doi: 10.1002/eji.201646373. Epub 2016 Nov 30. Eur J Immunol. 2017. PMID: 27861791 Free article.
FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.
De Silva P, Garaud S, Solinas C, de Wind A, Van den Eyden G, Jose V, Gu-Trantien C, Migliori E, Boisson A, Naveaux C, Duvillier H, Craciun L, Larsimont D, Piccart-Gebhart M, Willard-Gallo K. De Silva P, et al. Among authors: de wind a. EBioMedicine. 2019 Jan;39:226-238. doi: 10.1016/j.ebiom.2018.11.066. Epub 2018 Dec 20. EBioMedicine. 2019. PMID: 30579865 Free PMC article.
Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.
Solinas C, Garaud S, De Silva P, Boisson A, Van den Eynden G, de Wind A, Risso P, Rodrigues Vitória J, Richard F, Migliori E, Noël G, Duvillier H, Craciun L, Veys I, Awada A, Detours V, Larsimont D, Piccart-Gebhart M, Willard-Gallo K. Solinas C, et al. Among authors: de silva p, de wind a. Front Immunol. 2017 Oct 30;8:1412. doi: 10.3389/fimmu.2017.01412. eCollection 2017. Front Immunol. 2017. PMID: 29163490 Free PMC article.
Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity.
Noël G, Fontsa ML, Garaud S, De Silva P, de Wind A, Van den Eynden GG, Salgado R, Boisson A, Locy H, Thomas N, Solinas C, Migliori E, Naveaux C, Duvillier H, Lucas S, Craciun L, Thielemans K, Larsimont D, Willard-Gallo K. Noël G, et al. Among authors: de silva p, de wind a. J Clin Invest. 2021 Oct 1;131(19):e139905. doi: 10.1172/JCI139905. J Clin Invest. 2021. PMID: 34411002 Free PMC article.
BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.
Solinas C, Marcoux D, Garaud S, Vitória JR, Van den Eynden G, de Wind A, De Silva P, Boisson A, Craciun L, Larsimont D, Piccart-Gebhart M, Detours V, t'Kint de Roodenbeke D, Willard-Gallo K. Solinas C, et al. Among authors: de silva p, de wind a. Cancer Lett. 2019 May 28;450:88-97. doi: 10.1016/j.canlet.2019.02.027. Epub 2019 Feb 22. Cancer Lett. 2019. PMID: 30797818
Targeting PD-1 in cancer: Biological insights with a focus on breast cancer.
Solinas C, Aiello M, De Silva P, Gu-Trantien C, Migliori E, Willard-Gallo K. Solinas C, et al. Among authors: de silva p. Crit Rev Oncol Hematol. 2019 Oct;142:35-43. doi: 10.1016/j.critrevonc.2019.07.011. Epub 2019 Jul 21. Crit Rev Oncol Hematol. 2019. PMID: 31357142 Review.
Significance of TIM3 expression in cancer: From biology to the clinic.
Solinas C, De Silva P, Bron D, Willard-Gallo K, Sangiolo D. Solinas C, et al. Among authors: de silva p. Semin Oncol. 2019 Aug-Oct;46(4-5):372-379. doi: 10.1053/j.seminoncol.2019.08.005. Epub 2019 Nov 6. Semin Oncol. 2019. PMID: 31733828 Review.
337 results